EFDID: 313315EFD: View Filing

Issuer: INNOVATE BIOPHARMACEUTICALS, INC. (0001551986) - D

Accession: 0001551986-19-000060 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    INNOVATE BIOPHARMACEUTICALS, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    8480 HONEYCUTT ROAD
    SUITE 120

    RALEIGH, NC 27615
  • Persons:
    Related Persons 6
    Sandeep Laumas
    Executive Officer, Director
    Jay P Madan
    Executive Officer, Director
    Anthony E Maida III
    Director
    Lorin K Johnson
    Director
    Saira Ramasastry
    Director
    Roy Proujansky
    Director
EDGAR: Offering Information
  • Accession Date:
    05/31/2019
  • First Sale Date:
    05/17/2019
  • Offering Amount:
    $487,126
  • Amount Sold:
    $487,126
  • Exemptions:
    Rule 506
  • Security Type(s):
  • Sales Clarification:
    Warrants to purchase up to 3,897,010 shares common stock, $0.125 per warrant, with an exercise price of $2.72.
EFD: Current State Notices

Notices found in EFD

Filed:CA, NJ, OK, TX
Inactive:IL, NV
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
INNOVATE BIOPHARMACEUTICALS, INC.Jay P. MadanJay P. MadanChief Business Officer2019-05-31